• Latest Posts

Last exclusive interview from #BIO-Europe 2015: Andre Hoekema, SVP Corporate Development of Galapagos

Roche dishes out €509M for a Humanized antibody against Rheumatoid Arthritis

Fixing the ‘Galapagos-AbbVie Disaster’ through a Cystic Fibrosis Therapy

What Happened this Week? Abbvie abandons Galapagos, CRISPR Patent war to end and AI to exploit UK’s 100k genomes

AbbVie abandons Galapagos phase III and stock plummets 39% (and still dropping)


Now it’s Clear, AbbVie Has to Buy Galapagos’ Drug

Are AbbVie and J&J already fighting to acquire Galapagos’ pipeline?

GSK abandon its joint drug project with Galapagos